Megan Othus

Fred Hutchinson Cancer Research Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Roland B. Walter

University of Washington

UNITED STATES

View details

Jason Farrar

Assistant Professor

University of Arkansas for Medical Sciences

UNITED STATES

View details

Ryan D. Cassaday

Washington University School of Medicine

UNITED STATES

View details

Pamela Becker

Professor of Clinical Medicine

University of California, Irvine

UNITED STATES

View details

Stephanie Lee

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Filippo Milano

Associate Professor

Fred Hutch Cancer Center

UNITED STATES

View details

Phuong Vo

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Alexander J. Ambinder

Johns Hopkins University School of Medicine

UNITED STATES

View details

Michael Hochman

Assistant Professor

Winship Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Megan Othus

Research Interests

Explore related searches

Contact this professor

Articles (19)

CD34+ Cell Dose, Measurable Residual Disease, and Outcome After Myeloablative HLA-Matched Peripheral Blood Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia

Relationship between age, conditioning intensity, and outcome after allografting in adults age ≥60 years with AML

Biobanking and consent to future biospecimen use among adults enrolled in SWOG trials from 2000 to 2024

Modulators of relapse risk in adults allografted for acute myeloid leukemia in measurable residual disease-positive remission

A phase II basket trial of dual anti‐CTLA‐4 and anti‐PD‐1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

Endocrine therapy and risk of cardiovascular disease and mortality in postmenopausal breast cancer survivors

Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras

Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials

First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors

Design considerations for randomized comparisons of neoadjuvant–adjuvant versus adjuvant-only cancer immunotherapy when tumor measurement schedules do not align (SWOG S1801)

Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia

Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission

Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Evolution of eligibility criteria for non-transplant randomized controlled trials in adults with acute myeloid leukemia

Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Physician and patient perceptions on randomization of treatment intensity for unfit adults with acute myeloid leukemia and other high-grade myeloid neoplasm

Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies

Clinical trials: design, endpoints and interpretation of outcomes

Collaborators (9)

Roland B. Walter

Jason Farrar

Ryan D. Cassaday

Pamela Becker

Stephanie Lee

Filippo Milano

Phuong Vo

Alexander J. Ambinder

Michael Hochman

Make your next move.